25 XP   0   0   10

Ipsen SA
Buy, Hold or Sell?

Let's analyse Ipsen together

PenkeI guess you are interested in Ipsen SA. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Ipsen SA. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Ipsen SA

I send you an email if I find something interesting about Ipsen SA.

Quick analysis of Ipsen (30 sec.)










What can you expect buying and holding a share of Ipsen? (30 sec.)

How much money do you get?

How much money do you get?
€5.17
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
€45.86
Expected worth in 1 year
€68.70
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
€27.62
Return On Investment
25.0%

For what price can you sell your share?

Current Price per Share
€110.30
Expected price per share
€103.50 - €110.60
How sure are you?
50%

1. Valuation of Ipsen (5 min.)




Live pricePrice per Share (EOD)

€110.30

Intrinsic Value Per Share

€35.96 - €104.05

Total Value Per Share

€81.82 - €149.91

2. Growth of Ipsen (5 min.)




Is Ipsen growing?

Current yearPrevious yearGrowGrow %
How rich?$4.1b$3.6b$527m12.7%

How much money is Ipsen making?

Current yearPrevious yearGrowGrow %
Making money$697m$701.5m-$4.5m-0.7%
Net Profit Margin20.6%21.4%--

How much money comes from the company's main activities?

3. Financial Health of Ipsen (5 min.)




What can you expect buying and holding a share of Ipsen? (5 min.)

Welcome investor! Ipsen's management wants to use your money to grow the business. In return you get a share of Ipsen.

What can you expect buying and holding a share of Ipsen?

First you should know what it really means to hold a share of Ipsen. And how you can make/lose money.

Speculation

The Price per Share of Ipsen is €110.30. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Ipsen.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Ipsen, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €45.86. Based on the TTM, the Book Value Change Per Share is €5.71 per quarter. Based on the YOY, the Book Value Change Per Share is €7.31 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €1.19 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Ipsen.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps8.367.6%8.367.6%8.447.7%6.335.7%4.774.3%
Usd Book Value Change Per Share6.185.6%6.185.6%7.917.2%5.134.7%3.693.3%
Usd Dividend Per Share1.291.2%1.291.2%1.291.2%1.161.1%1.051.0%
Usd Total Gains Per Share7.476.8%7.476.8%9.208.3%6.305.7%4.744.3%
Usd Price Per Share116.72-116.72-108.71-94.28-88.80-
Price to Earnings Ratio13.96-13.96-12.88--16.51-4.67-
Price-to-Total Gains Ratio15.63-15.63-11.81--92.13--33.05-
Price to Book Ratio2.35-2.35-2.50-2.75-3.58-
Price-to-Total Gains Ratio15.63-15.63-11.81--92.13--33.05-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share119.31151
Number of shares8
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share1.291.16
Usd Book Value Change Per Share6.185.13
Usd Total Gains Per Share7.476.30
Gains per Quarter (8 shares)59.7550.36
Gains per Year (8 shares)238.99201.44
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
14119822937164191
28339546874328392
3124593707112493593
4165791946149657794
52079881185186821995
6248118614242239851196
72891384166326111491397
83311581190229813141598
93721779214133514781799
104141976238037216422000

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%9.01.00.090.0%21.01.00.095.5%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%9.01.00.090.0%18.04.00.081.8%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%20.00.02.090.9%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%9.01.00.090.0%19.03.00.086.4%

Fundamentals of Ipsen

About Ipsen SA

Ipsen S.A. operates as a biopharmaceutical company worldwide. The company provides drugs in the areas of oncology, neuroscience, and rare diseases. Its product pipeline comprises Cabometyx + Atezolizumab, which is in phase III clinical trial for the treatment of second line metastatic castration-resistant prostate cancer; lenalidomide and rituximab, and Taverik, which is in phase III for the treatment of second line follicular lymphoma; Bylvay, which is in phase III for the treatment of biliary atresia; Dysport, which is in phase III clinical trial for the treatment of chronic and episodic migraine; Fidrisertib, which is in phase II clinical trial for the treatment of fibrodysplasia ossificans progressiva; Elafibranor, which is in phase II for the treatment of primary sclerosing cholangitis, as well as IPN60250; IPN10200, which is in phase II for the treatment of longer-acting neurotoxin aesthetics and therapeutics; IPN60210, which is in phase I clinical trial for the treatment of relapsed/refractory multiple myeloma; and IPN60260 for the treatment of Viral cholestatic disease and is in phase I clinical trial. The company also offers Somatuline, Decapeptyl, Cabometyx, Onivyde, Tazverik, and other oncology products; Dysport and other neurosciences products; and Bylvay, NutropinAq, Increlex, and Sohonos for rare diseases. The company was founded in 1929 and is based in Boulogne-Billancourt, France.

Fundamental data was last updated by Penke on 2024-03-18 23:39:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Ipsen SA.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Ipsen earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Ipsen to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 20.6% means that €0.21 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Ipsen SA:

  • The MRQ is 20.6%. The company is making a huge profit. +2
  • The TTM is 20.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ20.6%TTM20.6%0.0%
TTM20.6%YOY21.4%-0.8%
TTM20.6%5Y17.1%+3.5%
5Y17.1%10Y15.3%+1.8%
1.1.2. Return on Assets

Shows how efficient Ipsen is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Ipsen to the Drug Manufacturers - Specialty & Generic industry mean.
  • 10.2% Return on Assets means that Ipsen generated €0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Ipsen SA:

  • The MRQ is 10.2%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 10.2%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ10.2%TTM10.2%0.0%
TTM10.2%YOY11.6%-1.4%
TTM10.2%5Y9.2%+1.0%
5Y9.2%10Y9.5%-0.2%
1.1.3. Return on Equity

Shows how efficient Ipsen is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Ipsen to the Drug Manufacturers - Specialty & Generic industry mean.
  • 16.8% Return on Equity means Ipsen generated €0.17 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Ipsen SA:

  • The MRQ is 16.8%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 16.8%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ16.8%TTM16.8%0.0%
TTM16.8%YOY19.4%-2.6%
TTM16.8%5Y16.5%+0.4%
5Y16.5%10Y16.8%-0.3%

1.2. Operating Efficiency of Ipsen SA.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Ipsen is operating .

  • Measures how much profit Ipsen makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Ipsen to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 31.4% means the company generated €0.31  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Ipsen SA:

  • The MRQ is 31.4%. The company is operating very efficient. +2
  • The TTM is 31.4%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ31.4%TTM31.4%0.0%
TTM31.4%YOY33.5%-2.1%
TTM31.4%5Y30.2%+1.1%
5Y30.2%10Y25.2%+5.0%
1.2.2. Operating Ratio

Measures how efficient Ipsen is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.69 means that the operating costs are €0.69 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Ipsen SA:

  • The MRQ is 0.686. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.686. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.686TTM0.6860.000
TTM0.686YOY0.665+0.021
TTM0.6865Y0.700-0.014
5Y0.70010Y0.746-0.046

1.3. Liquidity of Ipsen SA.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Ipsen is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.17 means the company has €1.17 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Ipsen SA:

  • The MRQ is 1.167. The company is just able to pay all its short-term debts.
  • The TTM is 1.167. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.167TTM1.1670.000
TTM1.167YOY1.795-0.628
TTM1.1675Y1.356-0.189
5Y1.35610Y1.436-0.080
1.3.2. Quick Ratio

Measures if Ipsen is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Ipsen to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.78 means the company can pay off €0.78 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Ipsen SA:

  • The MRQ is 0.785. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.785. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.785TTM0.7850.000
TTM0.785YOY1.484-0.699
TTM0.7855Y1.099-0.314
5Y1.09910Y1.186-0.087

1.4. Solvency of Ipsen SA.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Ipsen assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Ipsen to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.40 means that Ipsen assets are financed with 39.5% credit (debt) and the remaining percentage (100% - 39.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Ipsen SA:

  • The MRQ is 0.395. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.395. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.395TTM0.3950.000
TTM0.395YOY0.405-0.010
TTM0.3955Y0.470-0.075
5Y0.47010Y0.449+0.021
1.4.2. Debt to Equity Ratio

Measures if Ipsen is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Ipsen to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 65.3% means that company has €0.65 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Ipsen SA:

  • The MRQ is 0.653. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.653. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.653TTM0.6530.000
TTM0.653YOY0.681-0.027
TTM0.6535Y0.928-0.274
5Y0.92810Y0.845+0.083

2. Market Valuation of Ipsen SA

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Ipsen generates.

  • Above 15 is considered overpriced but always compare Ipsen to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 13.96 means the investor is paying €13.96 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Ipsen SA:

  • The EOD is 14.271. Based on the earnings, the company is underpriced. +1
  • The MRQ is 13.961. Based on the earnings, the company is underpriced. +1
  • The TTM is 13.961. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD14.271MRQ13.961+0.311
MRQ13.961TTM13.9610.000
TTM13.961YOY12.876+1.085
TTM13.9615Y-16.513+30.474
5Y-16.51310Y4.672-21.185
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Ipsen SA:

  • The EOD is 13.923. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 13.620. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 13.620. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD13.923MRQ13.620+0.303
MRQ13.620TTM13.6200.000
TTM13.620YOY11.623+1.997
TTM13.6205Y13.434+0.186
5Y13.43410Y9.751+3.684
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Ipsen is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 2.35 means the investor is paying €2.35 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Ipsen SA:

  • The EOD is 2.405. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.353. Based on the equity, the company is underpriced. +1
  • The TTM is 2.353. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.405MRQ2.353+0.052
MRQ2.353TTM2.3530.000
TTM2.353YOY2.503-0.150
TTM2.3535Y2.745-0.392
5Y2.74510Y3.582-0.837
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Ipsen SA compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--5.7105.7100%7.311-22%4.744+20%3.415+67%
Book Value Per Share--45.86445.8640%40.154+14%33.085+39%25.027+83%
Current Ratio--1.1671.1670%1.795-35%1.356-14%1.436-19%
Debt To Asset Ratio--0.3950.3950%0.405-2%0.470-16%0.449-12%
Debt To Equity Ratio--0.6530.6530%0.681-4%0.928-30%0.845-23%
Dividend Per Share--1.1951.1950%1.1950%1.075+11%0.970+23%
Eps--7.7297.7290%7.805-1%5.850+32%4.410+75%
Free Cash Flow Per Share--7.9227.9220%8.646-8%6.812+16%4.274+85%
Free Cash Flow To Equity Per Share--2.6952.6950%6.670-60%4.989-46%3.359-20%
Gross Profit Margin---0.423-0.4230%-0.285-33%2.824-115%0.590-172%
Intrinsic Value_10Y_max--104.049--------
Intrinsic Value_10Y_min--35.959--------
Intrinsic Value_1Y_max--8.109--------
Intrinsic Value_1Y_min--4.147--------
Intrinsic Value_3Y_max--26.129--------
Intrinsic Value_3Y_min--12.063--------
Intrinsic Value_5Y_max--46.280--------
Intrinsic Value_5Y_min--19.483--------
Market Cap9121291148.800+1%8996185374.8008996185374.8000%8351333422.500+8%7264215604.380+24%6826502176.517+32%
Net Profit Margin--0.2060.2060%0.214-4%0.171+21%0.153+35%
Operating Margin--0.3140.3140%0.335-6%0.302+4%0.252+24%
Operating Ratio--0.6860.6860%0.665+3%0.700-2%0.746-8%
Pb Ratio2.405+2%2.3532.3530%2.503-6%2.745-14%3.582-34%
Pe Ratio14.271+2%13.96113.9610%12.876+8%-16.513+218%4.672+199%
Price Per Share110.300+2%107.900107.9000%100.500+7%87.160+24%82.092+31%
Price To Free Cash Flow Ratio13.923+2%13.62013.6200%11.623+17%13.434+1%9.751+40%
Price To Total Gains Ratio15.975+2%15.62815.6280%11.815+32%-92.132+690%-33.049+311%
Quick Ratio--0.7850.7850%1.484-47%1.099-29%1.186-34%
Return On Assets--0.1020.1020%0.116-12%0.092+11%0.095+8%
Return On Equity--0.1680.1680%0.194-13%0.165+2%0.168+0%
Total Gains Per Share--6.9046.9040%8.506-19%5.820+19%4.386+57%
Usd Book Value--4136312630.0004136312630.0000%3609308390.000+15%2982290168.000+39%2252121034.000+84%
Usd Book Value Change Per Share--6.1766.1760%7.909-22%5.132+20%3.695+67%
Usd Book Value Per Share--49.61149.6110%43.434+14%35.788+39%27.072+83%
Usd Dividend Per Share--1.2921.2920%1.2930%1.163+11%1.050+23%
Usd Eps--8.3608.3600%8.443-1%6.328+32%4.770+75%
Usd Free Cash Flow--714462850.000714462850.0000%777201450.000-8%614016188.000+16%384977030.000+86%
Usd Free Cash Flow Per Share--8.5698.5690%9.353-8%7.368+16%4.623+85%
Usd Free Cash Flow To Equity Per Share--2.9152.9150%7.215-60%5.396-46%3.633-20%
Usd Market Cap9866500635.657+1%9731173719.9219731173719.9210%9033637363.118+8%7857702019.258+24%7384227404.338+32%
Usd Price Per Share119.312+2%116.715116.7150%108.711+7%94.281+24%88.799+31%
Usd Profit--697047480.000697047480.0000%701590620.000-1%525554762.000+33%395945468.000+76%
Usd Revenue--3383016750.0003383016750.0000%3272142500.000+3%3046088834.000+11%2484005063.000+36%
Usd Total Gains Per Share--7.4697.4690%9.201-19%6.295+19%4.744+57%
 EOD+4 -4MRQTTM+0 -0YOY+11 -255Y+28 -810Y+28 -8

3.2. Fundamental Score

Let's check the fundamental score of Ipsen SA based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1514.271
Price to Book Ratio (EOD)Between0-12.405
Net Profit Margin (MRQ)Greater than00.206
Operating Margin (MRQ)Greater than00.314
Quick Ratio (MRQ)Greater than10.785
Current Ratio (MRQ)Greater than11.167
Debt to Asset Ratio (MRQ)Less than10.395
Debt to Equity Ratio (MRQ)Less than10.653
Return on Equity (MRQ)Greater than0.150.168
Return on Assets (MRQ)Greater than0.050.102
Total8/10 (80.0%)

3.3. Technical Score

Let's check the technical score of Ipsen SA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5063.875
Ma 20Greater thanMa 50106.105
Ma 50Greater thanMa 100105.644
Ma 100Greater thanMa 200105.425
OpenGreater thanClose109.400
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets6,322,900
Total Liabilities2,499,000
Total Stockholder Equity3,825,100
 As reported
Total Liabilities 2,499,000
Total Stockholder Equity+ 3,825,100
Total Assets = 6,322,900

Assets

Total Assets6,322,900
Total Current Assets1,898,400
Long-term Assets4,424,500
Total Current Assets
Cash And Cash Equivalents 528,400
Short-term Investments 10,600
Net Receivables 737,500
Inventory 289,500
Other Current Assets 343,000
Total Current Assets  (as reported)1,898,400
Total Current Assets  (calculated)1,909,000
+/- 10,600
Long-term Assets
Property Plant Equipment 574,600
Goodwill 663,900
Intangible Assets 3,342,700
Long-term Assets  (as reported)4,424,500
Long-term Assets  (calculated)4,581,200
+/- 156,700

Liabilities & Shareholders' Equity

Total Current Liabilities1,626,800
Long-term Liabilities872,200
Total Stockholder Equity3,825,100
Total Current Liabilities
Short-term Debt 134,100
Short Long Term Debt 9,000
Accounts payable 771,400
Other Current Liabilities 679,900
Total Current Liabilities  (as reported)1,626,800
Total Current Liabilities  (calculated)1,594,400
+/- 32,400
Long-term Liabilities
Long-term Liabilities Other 247,300
Long-term Liabilities  (as reported)872,200
Long-term Liabilities  (calculated)247,300
+/- 624,900
Total Stockholder Equity
Common Stock83,800
Retained Earnings 644,400
Accumulated Other Comprehensive Income 3,096,900
Total Stockholder Equity (as reported)3,825,100
Total Stockholder Equity (calculated)3,825,100
+/-0
Other
Capital Stock83,800
Cash and Short Term Investments 528,400
Common Stock Shares Outstanding 83,375
Current Deferred Revenue41,400
Liabilities and Stockholders Equity 6,322,900
Net Debt -52,900
Net Invested Capital 3,834,100
Net Working Capital 271,600
Short Long Term Debt Total 475,500



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-31
> Total Assets 
662,333
665,896
619,713
942,509
1,214,273
1,322,922
1,569,840
1,576,868
1,678,194
1,633,391
1,561,088
1,565,332
1,713,300
1,938,000
2,423,500
3,072,000
3,377,400
4,306,900
4,313,000
4,990,500
5,607,900
6,322,900
6,322,9005,607,9004,990,5004,313,0004,306,9003,377,4003,072,0002,423,5001,938,0001,713,3001,565,3321,561,0881,633,3911,678,1941,576,8681,569,8401,322,9221,214,273942,509619,713665,896662,333
   > Total Current Assets 
0
0
291,001
507,681
611,765
636,811
689,062
652,362
639,778
632,750
606,349
601,845
671,600
809,900
1,050,400
1,016,400
1,185,600
1,346,500
1,578,800
1,953,800
2,397,600
1,898,400
1,898,4002,397,6001,953,8001,578,8001,346,5001,185,6001,016,4001,050,400809,900671,600601,845606,349632,750639,778652,362689,062636,811611,765507,681291,00100
       Cash And Cash Equivalents 
1,591
15,157
19,299
202,034
285,459
247,068
239,584
218,584
178,118
145,007
113,641
130,958
186,300
226,100
425,500
228,000
344,500
353,300
642,500
814,700
1,169,300
528,400
528,4001,169,300814,700642,500353,300344,500228,000425,500226,100186,300130,958113,641145,007178,118218,584239,584247,068285,459202,03419,29915,1571,591
       Short-term Investments 
112,388
87,344
72,587
18
901
6,096
2,528
1,162
49
9
516
150
100
6,800
6,600
29,600
5,500
59,300
26,800
42,400
31,000
10,600
10,60031,00042,40026,80059,3005,50029,6006,6006,8001001505169491,1622,5286,0969011872,58787,344112,388
       Net Receivables 
152,683
170,556
204,615
229,217
245,387
248,783
267,354
279,071
286,545
298,500
354,727
336,021
379,900
445,700
494,500
591,500
510,700
720,000
625,200
787,900
781,300
737,500
737,500781,300787,900625,200720,000510,700591,500494,500445,700379,900336,021354,727298,500286,545279,071267,354248,783245,387229,217204,615170,556152,683
       Other Current Assets 
15,201
14,035
2,000
2,040
1,972
53,849
63,652
50,575
62,917
71,400
9,608
13,253
-200
23,900
10,500
-100
126,400
-100
97,200
131,800
162,900
343,000
343,000162,900131,80097,200-100126,400-10010,50023,900-20013,2539,60871,40062,91750,57563,65253,8491,9722,0402,00014,03515,201
   > Long-term Assets 
0
0
328,712
434,828
602,508
686,111
880,778
924,506
1,038,416
1,000,641
954,739
963,487
1,041,700
1,128,100
1,373,100
2,055,600
2,191,800
2,960,400
2,734,200
3,036,700
3,210,300
4,424,500
4,424,5003,210,3003,036,7002,734,2002,960,4002,191,8002,055,6001,373,1001,128,1001,041,700963,487954,7391,000,6411,038,416924,506880,778686,111602,508434,828328,71200
       Property Plant Equipment 
161,462
157,354
152,786
187,769
198,186
221,891
237,860
249,972
282,287
271,728
281,781
287,483
309,600
348,700
379,000
418,900
474,500
679,300
646,600
647,500
581,400
574,600
574,600581,400647,500646,600679,300474,500418,900379,000348,700309,600287,483281,781271,728282,287249,972237,860221,891198,186187,769152,786157,354161,462
       Goodwill 
141,777
135,321
145,686
199,500
199,740
189,013
351,736
290,236
299,105
299,547
298,198
310,720
324,600
353,400
357,100
389,100
395,600
632,700
592,800
623,200
579,900
663,900
663,900579,900623,200592,800632,700395,600389,100357,100353,400324,600310,720298,198299,547299,105290,236351,736189,013199,740199,500145,686135,321141,777
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
8,100
29,500
42,300
37,000
165,800
173,600
111,400
0
0
0
0
0000111,400173,600165,80037,00042,30029,5008,10000000000000
       Intangible Assets 
145,222
152,587
15,049
29,136
57,299
89,169
163,911
236,967
166,538
430,931
129,175
144,787
160,600
151,200
380,100
930,100
1,012,000
1,382,900
1,713,900
1,993,200
2,165,300
3,342,700
3,342,7002,165,3001,993,2001,713,9001,382,9001,012,000930,100380,100151,200160,600144,787129,175430,931166,538236,967163,91189,16957,29929,13615,049152,587145,222
       Long-term Assets Other 
0
0
7,420
1,700
13,511
56,357
11,900
20,746
81,692
93,988
11,553
9,440
8,700
15,700
13,300
34,400
9,700
64,000
-589,000
-619,100
-573,700
-613,200
-613,200-573,700-619,100-589,00064,0009,70034,40013,30015,7008,7009,44011,55393,98881,69220,74611,90056,35713,5111,7007,42000
> Total Liabilities 
434,379
354,243
421,984
321,409
486,368
521,813
701,355
592,520
598,964
617,966
634,837
591,593
645,400
712,400
1,061,300
1,536,100
1,534,000
2,553,900
2,179,100
2,252,800
2,271,200
2,499,000
2,499,0002,271,2002,252,8002,179,1002,553,9001,534,0001,536,1001,061,300712,400645,400591,593634,837617,966598,964592,520701,355521,813486,368321,409421,984354,243434,379
   > Total Current Liabilities 
228,277
175,408
210,055
250,494
269,408
274,707
316,052
308,007
332,373
370,410
436,963
376,241
410,200
461,500
561,300
941,800
959,200
1,452,500
1,213,100
1,228,400
1,335,400
1,626,800
1,626,8001,335,4001,228,4001,213,1001,452,500959,200941,800561,300461,500410,200376,241436,963370,410332,373308,007316,052274,707269,408250,494210,055175,408228,277
       Short-term Debt 
0
0
5,421
10,010
10,936
11,536
6,259
17,183
4,190
4,176
4,353
9,603
10,100
16,100
7,000
64,700
37,700
285,100
406,600
123,700
104,600
134,100
134,100104,600123,700406,600285,10037,70064,7007,00016,10010,1009,6034,3534,1764,19017,1836,25911,53610,93610,0105,42100
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
25,400
7,200
6,500
7,000
64,700
37,700
285,100
2,800
5,500
3,800
9,000
9,0003,8005,5002,800285,10037,70064,7007,0006,5007,20025,40000000000000
       Accounts payable 
97,307
85,805
99,944
107,045
100,269
104,181
103,835
122,647
140,671
149,805
159,799
154,848
179,800
195,100
241,500
319,100
379,800
508,500
495,200
594,700
647,100
771,400
771,400647,100594,700495,200508,500379,800319,100241,500195,100179,800154,848159,799149,805140,671122,647103,835104,181100,269107,04599,94485,80597,307
       Other Current Liabilities 
70,043
84,554
104,690
14,088
10,837
130,950
151,461
157,338
173,085
181,345
66,142
38,003
35,600
43,300
50,700
79,300
541,700
244,100
305,900
504,000
578,500
679,900
679,900578,500504,000305,900244,100541,70079,30050,70043,30035,60038,00366,142181,345173,085157,338151,461130,95010,83714,088104,69084,55470,043
   > Long-term Liabilities 
0
0
211,929
70,915
216,960
247,106
385,303
284,513
266,591
247,556
197,874
215,352
235,200
250,900
500,000
594,300
574,800
1,101,400
966,000
1,024,400
935,800
872,200
872,200935,8001,024,400966,0001,101,400574,800594,300500,000250,900235,200215,352197,874247,556266,591284,513385,303247,106216,96070,915211,92900
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
297,100
297,500
297,900
696,300
639,100
772,200
667,000
0
0667,000772,200639,100696,300297,900297,500297,10000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
-5,421
-10,010
-10,936
-11,536
-6,259
-17,183
-4,190
-4,176
-4,353
-9,603
-10,100
-16,100
-7,000
-64,700
-37,700
-285,100
-280,300
1,100
5,100
-134,100
-134,1005,1001,100-280,300-285,100-37,700-64,700-7,000-16,100-10,100-9,603-4,353-4,176-4,190-17,183-6,259-11,536-10,936-10,010-5,42100
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
90,500
71,600
-200
-100
45,100
45,700
103,700
247,300
247,300103,70045,70045,100-100-20071,60090,50000000000000000
> Total Stockholder Equity
226,946
310,596
175,057
619,766
726,486
799,862
866,905
982,624
1,077,190
1,012,837
924,214
971,499
1,065,200
1,222,500
1,358,900
1,525,400
1,841,100
1,751,000
2,131,200
2,735,200
3,337,300
3,825,100
3,825,1003,337,3002,735,2002,131,2001,751,0001,841,1001,525,4001,358,9001,222,5001,065,200971,499924,2141,012,8371,077,190982,624866,905799,862726,486619,766175,057310,596226,946
   Retained Earnings 
73,657
101,437
83,001
119,230
144,006
150,611
147,164
156,584
95,271
424
-29,491
152,540
153,500
189,900
225,900
272,300
389,500
-50,700
548,000
646,600
648,600
644,400
644,400648,600646,600548,000-50,700389,500272,300225,900189,900153,500152,540-29,49142495,271156,584147,164150,611144,006119,23083,001101,43773,657
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
-300,699
-330,728
-374,855
-365,522
-376,710
-394,400
-442,500
-450,300
-456,400
-460,000
-491,400
2,027,200
2,652,200
3,238,400
3,096,900
3,096,9003,238,4002,652,2002,027,200-491,400-460,000-456,400-450,300-442,500-394,400-376,710-365,522-374,855-330,728-300,6990000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
732,900
739,100
741,700
741,900
122,300
1,983,900
2,547,400
0
02,547,4001,983,900122,300741,900741,700739,100732,90000000000000000
   Treasury Stock000-102,100-72,500-63,300-84,100-65,200-51,200-28,800-48,431-38,216-38,600-41,070-40,230-35,3360-1,2940000



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue3,127,500
Cost of Revenue-571,200
Gross Profit2,556,3002,556,300
 
Operating Income (+$)
Gross Profit2,556,300
Operating Expense-1,575,300
Operating Income981,000981,000
 
Operating Expense (+$)
Research Development619,300
Selling General Administrative217,800
Selling And Marketing Expenses917,100
Operating Expense1,575,3001,754,200
 
Net Interest Income (+$)
Interest Income0
Interest Expense-19,400
Other Finance Cost-35,100
Net Interest Income-54,500
 
Pretax Income (+$)
Operating Income981,000
Net Interest Income-54,500
Other Non-Operating Income Expenses0
Income Before Tax (EBT)761,5001,200,500
EBIT - interestExpense = 961,600
780,600
663,800
Interest Expense19,400
Earnings Before Interest and Taxes (EBIT)981,000780,900
Earnings Before Interest and Taxes (EBITDA)1,068,900
 
After tax Income (+$)
Income Before Tax761,500
Tax Provision-136,200
Net Income From Continuing Ops619,900625,300
Net Income644,400
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses2,146,500
Total Other Income/Expenses Net-219,50054,500
 

Technical Analysis of Ipsen
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Ipsen. The general trend of Ipsen is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Ipsen's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Ipsen SA.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 109.60 < 109.80 < 110.60.

The bearish price targets are: 109.70 > 109.10 > 103.50.

Tweet this
Ipsen SA Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Ipsen SA. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Ipsen SA Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Ipsen SA. The current macd is 1.3070572.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Ipsen price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Ipsen. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Ipsen price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Ipsen SA Daily Moving Average Convergence/Divergence (MACD) ChartIpsen SA Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Ipsen SA. The current adx is 14.86.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Ipsen shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Ipsen SA Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Ipsen SA. The current sar is 106.62.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Ipsen SA Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Ipsen SA. The current rsi is 63.87. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Ipsen SA Daily Relative Strength Index (RSI) ChartIpsen SA Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Ipsen SA. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Ipsen price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Ipsen SA Daily Stochastic Oscillator ChartIpsen SA Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Ipsen SA. The current cci is 120.60.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Ipsen SA Daily Commodity Channel Index (CCI) ChartIpsen SA Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Ipsen SA. The current cmo is 36.73.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Ipsen SA Daily Chande Momentum Oscillator (CMO) ChartIpsen SA Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Ipsen SA. The current willr is -14.81481481.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Ipsen SA Daily Williams %R ChartIpsen SA Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Ipsen SA.

Ipsen SA Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Ipsen SA. The current atr is 2.09690573.

Ipsen SA Daily Average True Range (ATR) ChartIpsen SA Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Ipsen SA. The current obv is -2,508,189.

Ipsen SA Daily On-Balance Volume (OBV) ChartIpsen SA Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Ipsen SA. The current mfi is 65.86.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Ipsen SA Daily Money Flow Index (MFI) ChartIpsen SA Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Ipsen SA.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-09STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-10STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-13RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-14MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-16RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-20BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-24WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside

6.3. Candlestick Patterns

Ipsen SA Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Ipsen SA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5063.875
Ma 20Greater thanMa 50106.105
Ma 50Greater thanMa 100105.644
Ma 100Greater thanMa 200105.425
OpenGreater thanClose109.400
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Ipsen with someone you think should read this too:
  • Are you bullish or bearish on Ipsen? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Ipsen? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Ipsen SA

I send you an email if I find something interesting about Ipsen SA.


Comments

How you think about this?

Leave a comment

Stay informed about Ipsen SA.

Receive notifications about Ipsen SA in your mailbox!